Founded in 2008, Zinc Group is a UK-based credit control, recoveries management, and business process outsourcing company operating in both the B2B and B2C markets with offices in Glasgow and Stratford-upon-Avon.
NICE’s updated advice says current evidence on the safety of the vaginal mesh shows there are serious, but well-recognised safety concerns.
The evidence for long-term efficacy is inadequate in quality and quantity. Therefore, the procedure should only be used in the context of research. This does not constitute a ban on the use of the procedure however.
NICE has published eight pieces of interventional procedure guidance (IPG) on mesh. It gives advice on the use of mesh as a treatment for stress urinary incontinence (SUI), or pelvic organ prolapse (POP).
The publication focuses on the use of mesh for vaginal wall prolapse, which is a type of POP. It is the last of eight IPGs to be updated.
Andrew Dillon, NICE chief executive, said: “Our updated advice on surgical procedures using mesh is based on the latest evidence available, which has been considered in the light of the serious concerns expressed by individual patients and patient groups. We emphasise the importance of patient consent and data collection and we are confident that our advice will give patients and health professionals the right information to make treatment decisions.”